These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 6266030

  • 21. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 22. [Hypotensive effect of carteolol in patients with essential hypertension].
    Beythien RD.
    Arzneimittelforschung; 1983 Nov; 33(2a):330-3. PubMed ID: 6682325
    [Abstract] [Full Text] [Related]

  • 23. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 24. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Dec; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 25. [Timolol administered once a day in uncomplicated hypertension. A trial in general practice].
    Enes B, Holmen J, Midthjell K, Nakrem S, Thorsvik D.
    Tidsskr Nor Laegeforen; 1978 Apr 20; 98(11):571-2. PubMed ID: 349769
    [No Abstract] [Full Text] [Related]

  • 26. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 27. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep 27; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 28. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
    Teitelbaum I, Chilvers M, Reiz RJ.
    Can J Cardiol; 2004 Oct 27; 20 Suppl C():11C-16C. PubMed ID: 16807618
    [Abstract] [Full Text] [Related]

  • 29. [Antihypertensive effects of timolol and of the combination timolol, amiloride and hydrochlorothiazide].
    Cospite M, Ferrara F, Raimondi F, Lo Presti T, Ballo M, Milio G, Meli F.
    Clin Ter; 1981 Sep 30; 98(6):617-26. PubMed ID: 7026143
    [No Abstract] [Full Text] [Related]

  • 30. [Timolol (Betim) in the treatment of essential hypertension in general practice. Single-dose and two-doses compared].
    Frimodt-Møller F, Arnold-Larsen AE.
    Ugeskr Laeger; 1981 Feb 23; 143(9):544-5. PubMed ID: 7025413
    [No Abstract] [Full Text] [Related]

  • 31. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
    Parry EE, Arr S, Tait D.
    Pharmatherapeutica; 1983 Feb 23; 3(5):294-9. PubMed ID: 6844366
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of timolol, hydrochlorothiazide and timolol-hydrochlorothiazide combination: study in 21 patients with mild to moderate essential arterial hypertension].
    Laplante L.
    Union Med Can; 1978 Mar 23; 107(3):317-26. PubMed ID: 636113
    [No Abstract] [Full Text] [Related]

  • 33. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD, Binstok G, Mullane JF, Woods JW, Pittman AW, del Greco F, Huang C, Morledge JH.
    Clin Ther; 1983 Mar 23; 5(5):525-39. PubMed ID: 6352036
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC, Leland TM, Cate EA, Stewart JA.
    J Glaucoma; 1998 Dec 23; 7(6):402-7. PubMed ID: 9871862
    [Abstract] [Full Text] [Related]

  • 35. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
    Dahlöf B, Jönsson L, Borgholst O, Ekblad G, Engstrand C, Grundestam I, Lindh A.
    Blood Press Suppl; 1993 Dec 23; 1():37-45. PubMed ID: 8173689
    [Abstract] [Full Text] [Related]

  • 36. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B, Hosie J.
    Blood Press Suppl; 1993 Dec 23; 1():22-9. PubMed ID: 8173687
    [Abstract] [Full Text] [Related]

  • 37. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I, Clineschmidt C, Polis A, Taylor J, Shedden A, Laibovitz R.
    J Glaucoma; 1998 Aug 23; 7(4):253-60. PubMed ID: 9713783
    [Abstract] [Full Text] [Related]

  • 38. The management vf essential hypertension with once daily administration of timolol maleate and bendrofluazide.
    Deering RB, Fox AS, Ison LJ.
    J Int Med Res; 1977 Aug 23; 5(2):114-9. PubMed ID: 326593
    [Abstract] [Full Text] [Related]

  • 39. [Field trial with a new betablocker (Solgol)].
    Piergies A, Schimert G.
    MMW Munch Med Wochenschr; 1980 Oct 17; 122(42):1473-6. PubMed ID: 6110182
    [Abstract] [Full Text] [Related]

  • 40. [The advantage of hypertension therapy with a once-daily beta-blocker-diuretic combination].
    Teufel W, Glocke M.
    Med Klin; 1981 Aug 28; 76(18):513-5. PubMed ID: 6116170
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.